SPOTLIGHT: Cougar Biotech raises $87M


Los Angeles-based Cougar Biotechnology announced that it has raised $87 million in a private placement. Much of that money will be spent on developing Cougar's drug candidates, including CB7630 (abiraterone acetate), CB3304 (noscapine) and CB1089 (seocalcitol). Cougar specializes in oncology drugs. Release